leisure time -WSS

leisure time

author：comprehensive 2025-09-27 13:10:43 - browse：731

Two boxes of Ozempic stack on each other, while one lean on the stack tilted — health coverage from STAT — SEBASTIEN BOZON/AFP via Getty Images

Novo Nordisk’s Ozempic cut the risk of death in a trial of patients with type 2 diabetes and chronic kidney disease, suggesting it may offer some added benefits over other classes of drugs approved to treat this population.

Specifically, the diabetes drug cut the risk of cardiovascular-related deaths by 29% and all-cause deaths by 20%. Given the study parameters, this implies that over three years, 39 people would need to be treated to prevent one death from any cause, according to new results presented Friday at a meeting of the European Renal Association and published in the New England Journal of Medicine.

Ozempic also lowered the risk of major heart complications — including cardiovascular-related death, heart attack, or stroke — by 18%, driven primarily by the reduced rate of heart-linked death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Asahi Kasei to buy Calliditas, picking up kidney disease drug

WSS

Pharma’s losing bet in New Jersey

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Chris Christie meets with Zelenskyy during Ukraine trip

Heart disease in astronauts blamed on cosmic radiation

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Pharma showers House GOP doctor with campaign cash

New air purifier tech could be key to improving indoor air quality

A controversial new treatment promises to make little people taller

Novavax promises a turnaround & Lilly roils the obesity market

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Apple is now the first public company to be valued at $3 trillion

U.S. death rates show how politics are affecting public health

Continuity nursing helped my family in our darkest PICU moments

How I helped Pfizer think through the ethics of Viagra

hotspot

CDC recommends RSV monoclonal antibody for infants

FDA approves Sage Therapeutics’ rapid

Stroke rates rising, especially in working

Congress: Prevent baby formula shortages by passing a new bill

Beyond aggravation: Constipation is an American epidemic

FDA scientists endorse Pfizer/BioNTech Covid

explore

hotspot

hotspot

entertainment